德国男男性行为者丙肝治愈后直接抗病毒药物时代再感染率与干扰素时代比较
该研究基于德国丙肝队列(GECCO)分析直接抗病毒药物(DAA)时代男男性行为者(MSM)丙肝再感染率,并与干扰素时代数据比较。2014年1月至2018年4月共2298人中有48例再感染(2%),总再感染发生率1.89/100人年;MSM再感染率9.02/100人年,显著高于注射吸毒者(PWID)的1.14/100人年,且MSM首次再感染率与干扰素时代相似(HR 1.05)。
要点
- MSM是DAA时代丙肝再感染的独立危险因素(OR 39.3)。
- MSM再感染率9.02/100人年,远高于PWID的1.14/100人年。
- MSM首次再感染率与干扰素时代无显著差异(HR 1.05)。
核心结论
- HCV再感染在德国MSM中仍常见,DAA时代MSM再感染率与干扰素时代相似。
- 除行为干预外,应针对MSM实施早期HCV治疗和再治疗以阻断传播。
研究设计与样本
- 多中心德国丙肝队列(GECCO)分析,比较再感染与未再感染患者。
- MSM再感染率与干扰素时代数据(NEAT网络)比较。
- 2014年1月至2018年4月,2298人、2346个治愈HCV感染 episodes。
主要发现
- 48例HCV再感染(2%),中位再感染时间500天(范围16-1160天)。
- 总再感染发生率1.89/100人年(95%CI 1.41-2.48)。
临床怎么用
- 对MSM丙肝治愈后应加强行为干预和随访监测再感染。
- MSM再感染后应尽早治疗和再治疗以预防HCV传播。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Micro-elimination of the hepatitis C virus (HCV) includes treatment in populations at risk of ongoing HCV transmission, such as men who have sex with men (MSM) or people who inject drugs (PWID). We analyzed the HCV reinfection incidence rates of participants in the German hepatitis C cohort (GECCO) and compared our data to previous findings from the interferon era. METHODS: Patients with HCV reinfections in the multi-centric GECCO cohort were compared to patients in whom no reinfection occurred. The HCV reinfection incidence rate in MSM was also compared to the incidence rate in the interferon era (using data from the European Acquired Immunodeficiency Syndrome Treatment Network [NEAT]). RESULTS: Between January 2014 and April 2018, 48 HCV reinfections occurred in 2298 individuals (2%), with 2346 cured HCV episodes. The median time to reinfection was 500 days (range 16-1160) and the overall HCV reinfection incidence rate was 1.89 per 100 person-years (py; 95% confidence interval [CI], 1.41-2.48). In a multivariate analysis, the transmission risk in MSM was the only independent risk factor of HCV reinfection (odds ratio, 39.3; 95% CI, 4.57-334.40; P = .001). The incidence rate in MSM was 9.02 (95% CI, 6.48-12.26) per 100 py, compared to 1.14 per 100 py in PWID (95% CI, .56-2.09). The incidence rate for a first HCV reinfection in MSM was similar in the direct-acting antiviral era, compared to the interferon era, with a hazard ratio of 1.05 (95% CI, .64-1.74; P = .831). CONCLUSIONS: HCV reinfection remains a frequent finding among MSM in Germany. In addition to behavioral interventions, early HCV treatment and retreatment should be implemented for this subgroup to prevent HCV transmission.
引用
- Ingiliz P, Wehmeyer MH, Boesecke C, et al. Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era. Clin Infect Dis. 2020. PMID: 31562816. doi:10.1093/cid/ciz949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。